ArticleBritish journal of clinical pharmacology2025

Effect of vepdegestrant, a PROTAC oestrogen receptor degrader, on dabigatran and rosuvastatin pharmacokinetics in healthy participants.

Derek Z Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.